NCT07341737 2026-01-15SL-28 for Advanced Solid TumoursSecond Life TherapeuticsPhase 1/2 Not yet recruiting60 enrolled
NCT05379985 2025-11-12Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RASRevolution Medicines, Inc.Phase 1/2 Recruiting754 enrolled
NCT03093116 2025-07-10TRIDENT-1Turning Point Therapeutics, Inc.Phase 1/2 Recruiting500 enrolled 2 FDA
NCT00838578 2024-04-26Phase I/II Study of KRN330 Plus Irinotecan in Patients With Metastatic Colorectal CancerKyowa Kirin Co., Ltd.Phase 1/2 Terminated65 enrolled 7 charts
NCT01681472 2020-09-25PK/PD Investigation of Modufolin (Arfolitixorin) in Plasma, Tumor and Adjacent Mucosa Adjacent Mucosa in Patients With Colon CancerIsofol Medical ABPhase 1/2 Completed32 enrolled 52 charts
NCT01397305 2020-09-09An Extended Feasibility Phase I/II Study of Methylenetetrahydrofolate (Arfolitixorin) and Pemetrexed Single Agent, Given as Neoadjuvant Treatment in Patients With Resectable Rectal CancerIsofol Medical ABPhase 1/2 Completed24 enrolled